tirzepatide dual agonist is a first-in-class targeting both GIP and GLP-1 receptors, offering a powerful and synergistic approach to glycaemic control and weight management. By acting on multiple metabolic pathways, tirzepatide: Enhances Semaglutide is built on a

GLP-1 promotes islet neogenesis, lowers blood glucose levels, upregulates Pdx1 expression, and increases -cell mass in db/db mice (Stoffers et al., 2000)

Because it is a peptide, it is sensitive to extreme temperatures

Rats were fed daily to maintain body weight at 90% of free-feeding weight and had ad libitum access to water

The peptide demonstrates a unique bidirectional capacity

Chemosphere 73:337343 Zhang Y, Chen Y, Sun L, Liang J, Guo Z, Xu L (2014) Protein phosphatases 2A as well as reactive oxygen species involved in tributyltin induced apoptosis in mouse livers

Interestingly, many additional benefits of taking the medication have been reported, including: Reduced cravings and thoughts around food The ability to view food as fuel rather than comfort Increased adherence to exercise plans Increased intake of vegetables Improved cardiovascular health Ozempic and Wegovy are given as a once-weekly self-injection